Search Results
Access to Prescribed PCSK9 Inhibitors Remains a Significant Barrier Leaving Patients at Risk for...
Overcoming Access Barriers and Practice Challenges to PCSK9 Inhibitor Implementation
Breaking Down the Barriers to PCSK9 Inhibitor Use in Clinically Appropriate Patients
PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events
PCSK9 Inhibitors: Cost Concerns and Access
Identifying Appropriate Patients for PCSK9 Inhibitors
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
Efficacy and Safety of PCSK9 Inhibitors
Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management
Dr Sergio Kaiser Optimizing Usage of PCSK9 Inhibitors
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
DRF 11: Barriers to Accessing Evidence Based Medicine
